Jaeck Daniel, Bachellier Philippe, Oussoultzoglou Elie, Weber Jean-Christophe, Wolf Philippe
Centre de Chirurgie Viscérale et de Transplantation, Hôpital Universitaire de Hautepierre, Avenue Molière, Strasbourg Cedex, France.
Liver Transpl. 2004 Feb;10(2 Suppl 1):S58-63. doi: 10.1002/lt.20041.
A multicenter retrospective review of 1467 patients treated by liver resection (LR) for hepatocellular carcinoma (HCC) in Europe over a 13-year period showed a mean mortality rate of 10.6%, which was correlated with the extent of LR, the etiology of cirrhosis and the study period with an improvement during the last years. Improved 5-year overall survival (20-51%) and disease-free survival (20-33%) reached similar rates in cirrhotic than in non-cirrhotic patients. Overall results were similar to those reported in Asian series as far as patients and tumor characteristics were comparable.
一项对欧洲1467例接受肝切除术（LR）治疗肝细胞癌（HCC）患者进行的为期13年的多中心回顾性研究显示，平均死亡率为10.6%，这与肝切除范围、肝硬化病因以及研究时期相关，且在过去几年有所改善。肝硬化患者和非肝硬化患者的5年总生存率（20%-51%）和无病生存率（20%-33%）改善后达到相似水平。就患者和肿瘤特征具有可比性而言，总体结果与亚洲系列报道的结果相似。
